
|Articles|February 28, 2020
Synteract Launches Rare Disease Institute
Advertisement
Synteract has launched the Synteract Rare Disease Institute. The program incorporates lectures, webinars, interactive discussions, videos, and industry literature that cover a wide variety of topics from patient perspectives, bioethics to customer engagement and more.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
3
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
4
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
5




